The pediatric bladder treatment market size is expected to see steady growth in the next few years. It will grow to $4.23 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to aging population, rising prevalence of chronic diseases in children, increasing access to healthcare, demand for personalized medicine in the treatment. Major trends in the forecast period include adoption of new and innovative pediatric bladder treatments, digital health technologies, early intervention and prevention, non-invasive treatments.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pediatric-bladder-treatment-global-market-report
Segmentation & Regional Insights
The pediatric bladder treatment market covered in this report is segmented –
1) By Type: Diurnal Incontinence; Enuresis; Other Types
2) By Treatment: Urotherapy; Medication; Surgical Reconstruction; Other Treatments
3) By Route of Administration: Oral; Parenteral; Other Route of Administrations
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End-Users
North America was the largest region in the pediatric bladder treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pediatric bladder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12943&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of pediatric bladder disorders is expected to propel the growth of the pediatric bladder treatment market going forward. Pediatric bladder disorders refer to various medical conditions that impact the normal functioning of the urinary bladder in children. Conditions such as spina bifida and neurological disorders contribute to urinary problems in children, necessitating effective treatments. For instance, in March 2023, according to a journal published by the Multidisciplinary Digital Publishing Institute (MDPI), a Switzerland-based publishing company, in a study involving 1,065 pediatric patients with neurogenic bladder (NGB), 38.9% of patients had spina bifida. The primary complication observed was lower urinary tract infection (18.1%), particularly prevalent among patients with open spina bifida (54.1%). Moreover, over a 12-month follow-up, common prevalent complications included lower urinary tract infections (18.1%), urinary incontinence (8.0%) and hydronephrosis (5.6%), with 7.9% of patients facing four or more recurring lower urinary tract infections. Therefore, the increasing prevalence of pediatric bladder disorders will drive the growth of the pediatric bladder treatment market.
Key Industry Players
Major players in the pediatric bladder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Medtronic PLC, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Mylan N.V., Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cook Medical Inc., Ipsen Pharma, Aurobindo Pharma Ltd., Endo International PLC, Coloplast AIS, Endo International PLC, Apotex Inc., Amneal Pharmaceuticals LLC., Orion Corporation, Taro Pharmaceuticals, Laborie Medical Technologies Corp., Salix Pharmaceuticals, TherapeuticsMD Inc., UroGen Pharma, Palette Life Sciences, Sumitovant Biopharma.
The pediatric bladder treatment market report table of contents includes:
- Executive Summary
- Pediatric Bladder Treatment Market Characteristics
- Pediatric Bladder Treatment Market Trends And Strategies
- Pediatric Bladder Treatment Market – Macro Economic Scenario
- Global Pediatric Bladder Treatment Market Size and Growth
.
.
.
- Global Pediatric Bladder Treatment Market Competitive Benchmarking
- Global Pediatric Bladder Treatment Market Competitive Dashboard
- Key Mergers And Acquisitions In Pediatric Bladder Treatment Market
- Pediatric Bladder Treatment Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- Pfizer Inc.
- Hoffmann-La Roche Ltd.
- AbbVie Inc
- Novartis AG
- Sanofi S.A
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
